| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000027856 |
| Receipt No. | R000031917 |
| Official scientific title of the study | A retrospective cohort study on the occurrence of sepsis after blood type incompatibility living liver transplantation |
| Date of disclosure of the study information | 2017/06/21 |
| Last modified on | 2017/06/21 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A retrospective cohort study on the occurrence of sepsis after blood type incompatibility living liver transplantation | |
| Title of the study (Brief title) | A retrospective cohort study on the occurrence of sepsis after blood type incompatibility living liver transplantation | |
| Region |
|
|
| Condition | ||
| Condition | A blood type incompatible living liver transplant patient | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the risk factors of postoperative sepsis after ABO-incompatible living liver transplantation at our hospital. |
| Basic objectives2 | Others |
| Basic objectives -Others | Perioperative factors are compared
between septic-onset group and non-sepsis group within 90 days after surgery. In this study, sepsis was referred to "International consensus definition of sepsis and septic shock Third Edition". That is, it was defined as an infection with an increase of 2 or more SOFA scores. Infections were defined based on criteria proposed by centers for disease prevention and prevention and reports on liver transplant related in the past. In addition, sepsis was compared with perioperative factors in the sepsis group and the non-sepsis group by referring to the above guidelines of sepsis, and the risk factors were examined. |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Classified the subject cases into septic
onset group and non-onset group, and compared the perioperative factors in both groups to examine risk factors for sepsis onset. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent ABO-I-LT between November 1997 and March 2016 at our department. | |||
| Key exclusion criteria | None | |||
| Target sample size | 17 | |||
| Research contact person | |
| Name of lead principal investigator | Yu Sawada |
| Organization | Yokohama City University |
| Division name | Department of Gastroenterological Surgery |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004 Japan |
| TEL | 045-787-2650 |
| t116036e@yokohama-cu.ac.jp | |
| Public contact | |
| Name of contact person | Yu Sawada |
| Organization | Yokohama City University |
| Division name | Department of Gastroenterological Surgery |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004 Japan |
| TEL | 045-787-2650 |
| Homepage URL | |
| t116036e@yokohama-cu.ac.jp | |
| Sponsor | |
| Institute | Yokohama City University
Department of Gastroenterological Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama City University
Department of Gastroenterological Surgery |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | This study is a retrospective cohort study at a single facility using existing medical record information. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031917 |